1-1 of 1
Suresh Devineni, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CD20 and CD22 with Rituximab in Combination with CMC-544 Results in Improved Anti-Tumor Activity Against Non-Hodgkin’s Lymphoma (NHL) Pre-Clinical Models.

Francisco J. Hernandez-Ilizaliturri, MD, Suresh Devineni, MD, Sarika Arora, MBBS, Joy Knight, MS, Myron S. Czuczman, MD
Journal: Blood
Blood (2005) 106 (11): 1473.
https://doi.org/10.1182/blood.V106.11.1473.1473
Published: 2005